Search

Your search keyword '"Ynsaurriaga, Fernando Arribas"' showing total 12 results
Start Over Author "Ynsaurriaga, Fernando Arribas" Search Limiters Full Text
12 results on '"Ynsaurriaga, Fernando Arribas"'

1. Impacto clínico del tratamiento a distancia de la insuficiencia cardiaca con la alerta multiparamétrica del DAI HeartLogic

Author

Bagudá, Javier De Juan, primary, León, Rocío Cózar, additional, Gavira Gómez, Juan J, additional, Pachón, Marta, additional, Artaza, Josebe Goirigolzarri, additional, Mateo, Virgilio Martínez, additional, Pérez, Vanessa Escolar, additional, Iniesta Manjavacas, Ángel Manuel, additional, Gándara, Nuria Rivas, additional, García, Jesús Álvarez, additional, Sánchez Ramos, Jesús Gabriel, additional, Agudo, Cristina Aguilera, additional, Rubín López, José Manuel, additional, Gallego, Alfonso Macías, additional, Fernández, Silvia López, additional, Torres, Luis González, additional, Martínez, Juan Gabriel, additional, Negrín, Natalia Marrero, additional, Maqueda, Javier Ramos, additional, Ramos, Mercedes Cabrera, additional, Medina Gil, José María, additional, Diego Rus, Carlos De, additional, Bermúdez Jiménez, Francisco José, additional, Madrazo, Inés, additional, Molina, Beatriz Díaz, additional, Marcos, Marta Cobo, additional, Ruiz Duthil, Ana Delia, additional, Cordero, David, additional, Méndez Fernández, Ana Belén, additional, Conde, Laura Peña, additional, Arcocha Torres, María F, additional, Castellan, Nicasio Pérez, additional, Arias, Miguel A, additional, Bolao, Ignacio García, additional, Infante, Ernesto Díaz, additional, Campari, Monica, additional, Ynsaurriaga, Fernando Arribas, additional, Delgado Jiménez, Juan F, additional, Valsecchi, Sergio, additional, and Bodes, Rafael Salguero, additional

Published
2024
Full Text
View/download PDF

3. Impacto del cateterismo derecho de ejercicio en el diagnóstico diferencial de la enfermedad tromboembólica pulmonar crónica

Author

Nieto, Sergio Huertas, primary, Martín, Maite Velázquez, additional, Cebada, Fernando Sarnago, additional, López-Guarch, Carmen Jiménez, additional, Melón, Nicolás Maneiro, additional, Camacho, Ángela Flox, additional, Cal, Teresa Segura De La, additional, Utrilla, Alejandro Cruz, additional, Colindres, Ricardo Aguilar, additional, Gude, María Jesús López, additional, Loaiza, Carlos Andrés Quezada, additional, Ostolaza, Yolanda Revilla, additional, Charterina, Sergio Alonso, additional, Cuervo, Covadonga Gómez, additional, Ynsaurriaga, Fernando Arribas, additional, and Subías, Pilar Escribano, additional

Published
2023
Full Text
View/download PDF

4. Patrones de presión arterial de 24 horas en pacientes con insuficiencia cardiaca estable. Prevalencia y factores asociados

Author

De Juan Bagudá, Javier, primary, Chaverri, Adriana Rodríguez, additional, Pérez, Pedro Caravaca, additional, Rodríguez, Fernando Aguilar, additional, García-Cosío Carmena, M Dolores, additional, Pérez, Sonia Mirabet, additional, López, María Luisa, additional, De La Cruz, Javier, additional, Guerra, José M, additional, Segura, Julián, additional, Ynsaurriaga, Fernando Arribas, additional, Ruilope, Luis Miguel, additional, and Delgado Jiménez, Juan F, additional

Published
2023
Full Text
View/download PDF

5. Systematic Workflow and Electrogram guidance to reduce X-ray Exposure Time during cryoballoon ablation of atrial fibrillation: the SWEET-Cryo strategy.

Author

Muñoz, Daniel Rodríguez, Castillo, Álvaro Marco del, Al-Mahdi, Ez Alddin Rajjoub, Rivera, Carla Lázaro, Cienfuegos, María Guisasola, Jiménez, Javier Ramos, Bernabé, Luis Borrego, Ynsaurriaga, Fernando Arribas, and Salguero-Bodes, Rafael

Abstract

Aims Cryoballoon pulmonary vein isolation (CB-PVI) offers similar efficacy to point-by-point radiofrequency PVI for patients with atrial fibrillation (AF), but generally with higher X-ray exposure. Strategies aimed at reducing fluoroscopy mostly rely on other costly imaging techniques, limiting their applicability. We designed a Systematic Workflow and Electrogram guidance to reduce X-ray Exposure Time during CB-PVI (SWEET-Cryo) strategy and analysed its impact on fluoroscopy use and acute procedural and clinical outcomes. Methods and results We enrolled 100 patients with paroxysmal or persistent AF undergoing CB-PVI by two operators with different levels of expertise. Patients treated with the SWEET-Cryo strategy (prospective cohort; n = 50) or conventional fluoroscopy (retrospective control cohort; n = 50) were compared. When applied by the senior operator, the SWEET-Cryo strategy significantly reduced the mean fluoroscopy time (FT) (2.6 ± 1.25 vs. 20.3 ± 10.8 min) and mean dose area product (DAP) (5.1 ± 3.8 vs. 35.3 ± 22.3 Gy cm2) compared with those of the control group, respectively (P < 0.001). Significant reductions in FT (6.4 ± 2.5 min vs. 32.5 ± 10.05) and DAP (13.9 ± 7.7 vs. 92.3 ± 63.8) were also achieved by the less experienced operator (P < 0.001). No difference was observed in acute and long-term complications or freedom from AF between fluoroscopy strategies during a 33-month median follow-up. Mean FT was maintained below 3 min in randomly selected cases performed during the follow-up period. Conclusion In contrast to conventional protocols and regardless of the operator's experience, the optimized SWEET-Cryo strategy dramatically reduced fluoroscopy exposure during CB-PVI. The efficacy, safety, or added costs of the ablation procedure were not compromised. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

6. Effect of Coronavirus Disease 2019 in Pulmonary Circulation. The Particular Scenario of Precapillary Pulmonary Hypertension

Author

Nuche, Jorge, primary, Segura de la Cal, Teresa, additional, Jiménez López Guarch, Carmen, additional, López-Medrano, Francisco, additional, Delgado, Carmen Pérez-Olivares, additional, Ynsaurriaga, Fernando Arribas, additional, Delgado, Juan F., additional, Ibáñez, Borja, additional, Oliver, Eduardo, additional, and Subías, Pilar Escribano, additional

Published
2020
Full Text
View/download PDF

8. Potential Role of Natriuretic Response to Furosemide Stress Test During Acute Heart Failure.

Author

Pérez, Pedro Caravaca, Nuche, Jorge, Fernández, Laura Morán, Lora, David, Blázquez-Bermejo, Zorba, López-Azor, Juan Carlos, de Juan Bagudá, Javier, García-Cosío Carmena, María Dolores, Subías, Pilar Escribano, Salguero-Bodes, Rafael, Ynsaurriaga, Fernando Arribas, and Delgado, Juan F.

Abstract

Poor natriuresis has been associated with a poorer response to diuretic treatment and worse prognosis in acute heart failure. Recommendations on how and when to measure urinary sodium (UNa) are lacking. We aim to evaluate UNa quantification after a furosemide stress test (FST) capacity to predict appropriate decongestion during acute heart failure hospitalization. METHODS: Patients underwent an FST on day-1 of admission, and UNa was measured 2 hours after, dividing patients into low or high UNa based on the sample median value. A semiquantitative composite congestive score (CCS; 0–9) and NT pro-BNP (N-terminal pro-B-type natriuretic peptide) quantification were assessed before the FST and at day 5 after the FST. RESULTS: Median UNa after FST in the 65 patients included was 113 (97–122) mmol/L. At day 5, a lower proportion of patients with a low UNa reached a 30% decrease in NT-proBNP levels (21 [66%] for low UNa versus 31 [94%] for high UNa; P=0.005) and an appropriate grade of decongestion (CCS<3) (20 [62%] for low UNa versus 32 [97%] for high UNa; P<0.001). A UNa>83 mmol/L 2 hours after FST had a 96% sensitivity to predict an NT-proBNP reduction ≥30% and 95% to predict a CCS<3 at day 5. Low UNa patients presented a lower cumulative diuresis and weight loss and presented more often with prolonged hospitalization, worsening heart failure, and readmission because of acute heart failure or death at 6 months. CONCLUSIONS: Low natriuresis after an FST identified patients at a higher risk of an inadequate diuretic response and an inappropriate decongestion. FST-guided diuretic treatment might help to improve decongestion, shorten hospitalizations, and to reduce adverse outcomes. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

10. Comentarios a la guía ESC/EAS 2016 sobre el tratamiento de las dislipemias

Author

Pérez de Isla, L., primary, de Isla, Leopoldo Pérez, additional, Fernández, Pedro Luis Sánchez, additional, Walther, Luis Álvarez-Sala, additional, Alonso, Vivencio Barrios, additional, Conde, Almudena Castro, additional, Basilio, Enrique Galve, additional, Ortiz, Luis García, additional, López, Pedro Mata, additional, Ezquerra, Eduardo Alegría, additional, Fort, Alberto Cordero, additional, Sales, Juan Cosin, additional, Cervantes, Carlos Escobar, additional, Marimón, Xavier García-Moll, additional, Doblas, Juan José Gómez, additional, Martín, Domingo Marzal, additional, Eizagaechevarria, Nekane Murga, additional, de Pablo Zarzosa, Carmen, additional, Rincón, Luis Miguel, additional, Forés, Juan Sanchis, additional, Calvar, José Alberto San Román, additional, Manterola, Fernando Alfonso, additional, Ynsaurriaga, Fernando Arribas, additional, Masip, Arturo Evangelista, additional, González, Ignacio Ferreira, additional, Navarro, Manuel Jiménez, additional, Ortuño, Francisco Marín, additional, Padial, Luis Rodríguez, additional, Green, Alessandro Sionis, additional, and García, Rafael Vázquez, additional

Published
2017
Full Text
View/download PDF

11. Tratamiento a distancia de la insuficiencia cardiaca mediante el algoritmo HeartLogic. Registro RE-HEART

Author

de Juan Bagudá, Javier, Gómez, Juan J. Gavira, Iglesias, Marta Pachón, León, Rocío Cózar, Pérez, Vanessa Escolar, Fernández, Óscar González, Gándara, Nuria Rivas, Artaza, Josebe Goirigolzarri, Molina, Beatriz Díaz, Gallego, Alfonso Macías, Mateo, Virgilio Martínez, Martínez, Juan G. Martínez, Negrín, Natalia Marrero, Salinas, Gonzalo L. Alonso, Torres, Luis González, Jiménez, Juan F. Delgado, Sánchez-Aguilera, Paula, Infante, Ernesto Díaz, Torres, María F. Arcocha, Conde, Laura Peña, Fernández, Ana B. Méndez, Castellano, Nicasio Pérez, López, José M. Rubín, Delgado, Inés Madrazo, Fernández-Anguita, Manuel J., Ruiz, Pablo Ramos, Moreno, Olga Medina, Pereda, David Cordero, Rus, Carlos de Diego, Ynsaurriaga, Fernando Arribas, Bolao, Ignacio García, and Bodes, y. Rafael Salguero

Abstract

HeartLogic es un algoritmo multiparamétrico incorporado a desfibriladores automáticos implantables (DAI). La alerta asociada predice descompensaciones de insuficiencia cardiaca (IC). Nuestro objetivo es analizar la asociación entre alertas y eventos clínicos bajo un protocolo de seguimiento común en un registro multicéntrico.

Published
2021
Full Text
View/download PDF

12. Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure.

Author

López-Azor JC, de la Torre N, García-Cosío Carmena MD, Caravaca Pérez P, Munera C, MarcoClement I, Cózar León R, Álvarez-García J, Pachón M, Ynsaurriaga FA, Salguero Bodes R, Delgado Jiménez JF, and de Juan Bagudá J

Abstract

Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac defibrillators and cardiac resynchronisation therapy, allows monitoring of the nocturnal heart rate, respiratory movements, thoracic impedance, physical activity and the intensity of heart tones, with the aim of predicting major clinical events. Although HeartLogic has demonstrated high sensitivity for the detection of heart failure decompensations, its effects on hospitalisation and mortality in randomised clinical trials has not yet been corroborated. This review details how the HeartLogic algorithm works, compiles available evidence from clinical studies, and discusses its application in daily clinical practice., Competing Interests: Disclosure: RCL declares fees for consultancy work from Boston Scientific. FAY declares fees for consultancy work and presentations from Boston Scientific, Medtronic and Abbott. RSB declares fees for consultancy work from Boston Scientific. JdJB declares fees for consultancy work and presentations from Boston Scientific. All other authors have no conflicts of interest to declare., (Copyright © 2022, Radcliffe Cardiology.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results